News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
VANLENT ANNE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 01/03/2023 |
3
| VANLENT ANNE (Director) has filed a Form 3 on ObsEva SA |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.25, valued at
$45k
|
|
| 12/18/2020 |
4
| VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 12,000 options to buy
@ $4.72, valued at
$56.6k
|
|
| 06/15/2020 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 14,210 options to buy
@ $4.1, valued at
$58.3k
|
|
| 12/06/2019 |
4
| VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 10,000 options to buy
@ $3.02, valued at
$30.2k
|
|
| 06/14/2019 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 9,000 options to buy
@ $0.68, valued at
$6.1k
Granted 12,700 options to buy
@ $0.68, valued at
$8.6k
|
|
| 05/13/2019 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Converted 20,983 shares
@ $0
Bought 5,000 shares
@ $10, valued at
$50k
Converted 107,977 preferred shares
@ $0
Converted 47,807 preferred shares
@ $0 |
|
| 05/08/2019 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 23,684 options to buy
@ $10, valued at
$236.8k
|
|
| 05/07/2019 |
3
| VANLENT ANNE (Director) has filed a Form 3 on Trevi Therapeutics, Inc. |
| 11/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2018 |
4/A
| VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 10,000 options to buy
@ $4.25, valued at
$42.5k
|
|
| 07/27/2018 |
4
| VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 8,000 options to buy
@ $4.25, valued at
$34k
|
|
| 12/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2017 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Granted 12,500 shares
@ $0 |
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/18/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/15/2016 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.26, valued at
$28.3k
|
|
| 05/13/2016 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Aviragen Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.5, valued at
$30k
|
|
| 08/13/2015 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Granted 5,000 options to buy
@ $2.49, valued at
$12.5k
|
|
| 06/29/2015 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.|
Txns:
| Granted 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
| 06/24/2015 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Bought 35,000 shares
@ $2.1969, valued at
$76.9k
|
|
| 06/22/2015 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.76, valued at
$37.6k
|
|
| 06/17/2015 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.69, valued at
$26.9k
|
|
|
|
|